Atom Investors’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,277
| Closed | -$111K | – | 530 |
|
|
2024
Q4 | $111K | Buy |
+14,277
| New | +$111K | 0.01% | 447 |
|
|
2024
Q3 | – | Sell |
-23,174
| Closed | -$195K | – | 487 |
|
|
2024
Q2 | $195K | Sell |
23,174
-17,308
| -43% | -$146K | 0.02% | 429 |
|
|
2024
Q1 | $272K | Sell |
40,482
-62,734
| -61% | -$422K | 0.03% | 426 |
|
|
2023
Q4 | $607K | Buy |
103,216
+65,818
| +176% | +$387K | 0.11% | 247 |
|
|
2023
Q3 | $365K | Buy |
37,398
+24,104
| +181% | +$235K | 0.08% | 287 |
|
|
2023
Q2 | $157K | Sell |
13,294
-10,152
| -43% | -$120K | 0.06% | 257 |
|
|
2023
Q1 | $253K | Sell |
23,446
-60,898
| -72% | -$657K | 0.14% | 173 |
|
|
2022
Q4 | $975K | Buy |
84,344
+47,382
| +128% | +$548K | 0.49% | 54 |
|
|
2022
Q3 | $551K | Sell |
36,962
-42,799
| -54% | -$638K | 0.19% | 142 |
|
|
2022
Q2 | $719K | Sell |
79,761
-35,667
| -31% | -$322K | 0.31% | 92 |
|
|
2022
Q1 | $865K | Buy |
115,428
+54,068
| +88% | +$405K | 0.4% | 59 |
|
|
2021
Q4 | $526K | Buy |
+61,360
| New | +$526K | 0.09% | 144 |
|